Catabasis Pharmaceuticals Inc (NASDAQ:CATB) got downgraded
Catabasis Pharmaceuticals Inc (NASDAQ:CATB) currently trades at $1.20 which is about 1.69% higher than the 52-week high of $8.15. The trading volume at ready counter …
Catabasis Pharmaceuticals Inc (NASDAQ:CATB) currently trades at $1.20 which is about 1.69% higher than the 52-week high of $8.15. The trading volume at ready counter …